Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Axonics Inc (NQ: AXNX )

69.58 +0.05 (+0.07%)
Streaming Delayed Price Updated: 10:23 AM EDT, Sep 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Axonics Inc

< Previous 1 2 3 4 5 6 7 Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Axonics Announces Definitive Agreement to be Acquired by Boston Scientific
From Axonics, Inc.
Via Business Wire
Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue
From Axonics, Inc.
Via Business Wire
Axonics to Present at the J.P. Morgan Healthcare Conference
From Axonics, Inc.
Via Business Wire
Peeling Back The Layers: Exploring Axonics Through Analyst Insights
Via Benzinga
Earnings Outlook For Axonics
Via Benzinga
Revolutionizing Care: NeuroQure’s Groundbreaking Path to Treating Genetic Intellectual Disabilities
From NeuroQure
Via GlobeNewswire
Axonics to Participate in November Investor Conferences
From Axonics, Inc.
Via Business Wire
Axonics Reports Third Quarter 2023 Financial Results
From Axonics, Inc.
Via Business Wire
Analyst Ratings for Axonics
Via Benzinga
Why Shares of Axonics Rose Friday
The company showed improved revenue and margins in its second-quarter report. 
Via The Motley Fool
Earnings Outlook For Axonics
Via Benzinga
The Latest Analyst Ratings for Axonics
Via Benzinga
Earnings Scheduled For October 30, 2023
Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter. 
Via Benzinga
Where Axonics Stands With Analysts
Via Benzinga
Axonics to Report Third Quarter 2023 Financial Results on October 30
From Axonics, Inc.
Via Business Wire
Axonics to Participate in September Investor Conferences
From Axonics, Inc.
Via Business Wire
Axonics Announces CFO Retirement and Appoints Successor
From Axonics, Inc.
Via Business Wire
Analyst Ratings for Axonics
Via Benzinga
Axonics Earnings Preview
Via Benzinga
Axonics Reports Second Quarter 2023 Financial Results
From Axonics, Inc.
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Axonics Positioned For Rapid Penetration In Underserved Market, Analyst Initiates With Bullish Tone
KeyBanc Capital markets initiated coverage on Axonics Inc (NASDAQ: AXNX) with an Overweight rating and a  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
Via Benzinga
Axonics to Report Second Quarter 2023 Financial Results on July 27
From Axonics, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
Via Benzinga
Axonics Q1 Soars Past Estimates: Analysts Say Annual Sales Outlook Is 'Conservative'
Axonics Inc (NASDAQ: AXNX) reported a Q1 EPS loss of $(0.19), better than the consensus of $(0.29). 
Via Benzinga
Axonics Reports First Quarter 2023 Financial Results
From Axonics, Inc.
Via Business Wire
Earnings Scheduled For May 1, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.